The predictive value of a prognostic risk model constructed for three aging-associated genes in glioma.

IF 1.8 4区 医学 Q4 ENGINEERING, BIOMEDICAL
Technology and Health Care Pub Date : 2025-09-01 Epub Date: 2025-04-30 DOI:10.1177/09287329251333904
Jun Wang, Qi Zhou, Eryi Sun, Guangzhao Li, Zheng Li, Zhong Wang
{"title":"The predictive value of a prognostic risk model constructed for three aging-associated genes in glioma.","authors":"Jun Wang, Qi Zhou, Eryi Sun, Guangzhao Li, Zheng Li, Zhong Wang","doi":"10.1177/09287329251333904","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Gliomas are malignant brain tumors with poor prognosis, and aging is believed to play a role in their malignant transformation. However, the relationship between aging and glioma prognosis remains unclear.</p><p><strong>Objective: </strong>This study aims to construct and validate a prognostic risk model based on aging-related differential expression genes (ARDEGs) to understand their role in glioma prognosis and tumorigenesis, with a particular focus on immune responses.</p><p><strong>Methods: </strong>ARDEGs were identified between LGG and HGG through LASSO regression and Cox regression. A prognostic risk model was developed and validated. GSEA and KEGG pathway analyses were performed to explore tumorigenic mechanisms in high- and low-risk groups. The correlation between the model genes and immune cell infiltration, as well as immune checkpoint molecules, was also analyzed. The protein expression of NOG was evaluated in glioma cells using WB and IHC.</p><p><strong>Results: </strong>Three aging-related genes-IGFBP2, AGTR1, and NOG-were identified, and a prognostic model was established. KEGG and GSEA analysis revealed that the high-risk group enriched pathways related to inflammation and immune responses, while the low-risk group showed enrichment in oxidative phosphorylation and metabolism pathways. IGFBP2 and AGTR1 expression correlated positively with immunosuppressive cells and immune checkpoint molecules, whereas NOG showed an opposite trend. NOG protein expression was reduced in glioma cells and lower in high-grade gliomas compared to low-grade gliomas.</p><p><strong>Conclusions: </strong>The prognostic risk model based on aging-related genes shows strong predictive power for glioma prognosis, highlighting the potential role of immune-related pathways and NOG in tumor progression.</p>","PeriodicalId":48978,"journal":{"name":"Technology and Health Care","volume":" ","pages":"2232-2243"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technology and Health Care","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/09287329251333904","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Gliomas are malignant brain tumors with poor prognosis, and aging is believed to play a role in their malignant transformation. However, the relationship between aging and glioma prognosis remains unclear.

Objective: This study aims to construct and validate a prognostic risk model based on aging-related differential expression genes (ARDEGs) to understand their role in glioma prognosis and tumorigenesis, with a particular focus on immune responses.

Methods: ARDEGs were identified between LGG and HGG through LASSO regression and Cox regression. A prognostic risk model was developed and validated. GSEA and KEGG pathway analyses were performed to explore tumorigenic mechanisms in high- and low-risk groups. The correlation between the model genes and immune cell infiltration, as well as immune checkpoint molecules, was also analyzed. The protein expression of NOG was evaluated in glioma cells using WB and IHC.

Results: Three aging-related genes-IGFBP2, AGTR1, and NOG-were identified, and a prognostic model was established. KEGG and GSEA analysis revealed that the high-risk group enriched pathways related to inflammation and immune responses, while the low-risk group showed enrichment in oxidative phosphorylation and metabolism pathways. IGFBP2 and AGTR1 expression correlated positively with immunosuppressive cells and immune checkpoint molecules, whereas NOG showed an opposite trend. NOG protein expression was reduced in glioma cells and lower in high-grade gliomas compared to low-grade gliomas.

Conclusions: The prognostic risk model based on aging-related genes shows strong predictive power for glioma prognosis, highlighting the potential role of immune-related pathways and NOG in tumor progression.

脑胶质瘤中三种衰老相关基因构建的预后风险模型的预测价值。
神经胶质瘤是一种预后较差的恶性脑肿瘤,其恶性转化与衰老有关。然而,衰老与胶质瘤预后之间的关系尚不清楚。目的构建并验证基于衰老相关差异表达基因(ARDEGs)的预后风险模型,了解其在胶质瘤预后和肿瘤发生中的作用,并重点关注免疫反应。方法采用LASSO回归和Cox回归对LGG和HGG的差异进行分析。建立并验证了预后风险模型。通过GSEA和KEGG通路分析探讨高危组和低危组的致瘤机制。分析了模型基因与免疫细胞浸润及免疫检查点分子的相关性。用WB和IHC检测胶质瘤细胞中NOG蛋白的表达。结果检测到igfbp2、AGTR1、nog 3个衰老相关基因,并建立预后模型。KEGG和GSEA分析显示,高风险组富集了与炎症和免疫应答相关的途径,而低风险组富集了氧化磷酸化和代谢途径。IGFBP2和AGTR1的表达与免疫抑制细胞和免疫检查点分子呈正相关,而NOG则相反。与低级别胶质瘤相比,NOG蛋白在胶质瘤细胞中的表达降低,在高级别胶质瘤中的表达更低。结论基于衰老相关基因的神经胶质瘤预后风险模型具有较强的预测能力,突出了免疫相关通路和NOG在肿瘤进展中的潜在作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Technology and Health Care
Technology and Health Care HEALTH CARE SCIENCES & SERVICES-ENGINEERING, BIOMEDICAL
CiteScore
2.10
自引率
6.20%
发文量
282
审稿时长
>12 weeks
期刊介绍: Technology and Health Care is intended to serve as a forum for the presentation of original articles and technical notes, observing rigorous scientific standards. Furthermore, upon invitation, reviews, tutorials, discussion papers and minisymposia are featured. The main focus of THC is related to the overlapping areas of engineering and medicine. The following types of contributions are considered: 1.Original articles: New concepts, procedures and devices associated with the use of technology in medical research and clinical practice are presented to a readership with a widespread background in engineering and/or medicine. In particular, the clinical benefit deriving from the application of engineering methods and devices in clinical medicine should be demonstrated. Typically, full length original contributions have a length of 4000 words, thereby taking duly into account figures and tables. 2.Technical Notes and Short Communications: Technical Notes relate to novel technical developments with relevance for clinical medicine. In Short Communications, clinical applications are shortly described. 3.Both Technical Notes and Short Communications typically have a length of 1500 words. Reviews and Tutorials (upon invitation only): Tutorial and educational articles for persons with a primarily medical background on principles of engineering with particular significance for biomedical applications and vice versa are presented. The Editorial Board is responsible for the selection of topics. 4.Minisymposia (upon invitation only): Under the leadership of a Special Editor, controversial or important issues relating to health care are highlighted and discussed by various authors. 5.Letters to the Editors: Discussions or short statements (not indexed).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信